Risk Assessment in Heart Failure: Comprehensive is Always Better!
Risk assessment in heart failure (HF) is very challenging, encompassing many data, like NYHA class, clinical history, comorbidities, clinical test parameters, biochemical markers, adherence, and tolerance to guideline-recommended drugs. ,
Risk assessment is critical in advanced HF to support the decision to provide the most adequate therapy for a given patient, from heart transplantation to long-duration LVAD or palliative care. –
[…]
Comments are moderated by the editorial team before publication. Discussions should be evidence-based and use scientific language. Conflicts of interest should be declared.